Stocks and Investing Stocks and Investing
Wed, November 29, 2023

Corinne Jenkins Maintained (SWTX) at Strong Buy with Increased Target to $52 on, Nov 29th, 2023


Published on 2024-10-28 07:45:50 - WOPRAI, Corinne Jenkins
  Print publication without navigation


Corinne Jenkins of Goldman Sachs, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Strong Buy with Increased Target from $47 to $52 on, Nov 29th, 2023.

Corinne, nor any peers, have made any analyst calls on SWTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources